EMAIL THIS PAGE TO A FRIEND

Oncotarget

The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling.


PMID 26517515

Abstract

Previously we reported that valproic acid (VPA) acts in synergy with GOS to enhance cell death in human DU145 cells. However, the underlying mechanism remains elusive. In this study, we observed that such synergistic cytotoxicity of GOS and VPA could be extended to human A375, HeLa, and PC-3 cancer cells. GOS and VPA co-treatment induced robust apoptosis as evidenced by caspase-8/-9/-3 activation, PARP cleavage, and nuclear fragmentation. GOS and VPA also markedly decreased cyclin A2 protein expression. Owing to the reduction of cyclin A2, Akt signaling was suppressed, leading to dephosphorylation of FOXO3a. Consequently, FOXO3a was activated and the expression of its target genes, including pro-apoptotic FasL and Bim, was upregulated. Supporting this, FOXO3a knockdown attenuated FasL and Bim upregulation and apoptosis induction in GOS+VPA-treated cells. Furthermore, blocking proteasome activity by MG132 prevented the downregulation of cyclin A2, dephosphorylation of Akt and FOXO3a, and induction of apoptosis in cells co-treated with GOS and VPA. In mouse model, GOS and VPA combination significantly inhibited the growth of A375 melanoma xenografts. Our findings indicate that GOS and VPA co-treatment induces apoptosis in human cancer cells by suppressing the cyclin-A2/Akt/FOXO3a pathway.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1405470
Anti-BIRC5 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA002830
Anti-BIRC5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1405570
Anti-CCNA2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV03045
Anti-CCNA2 antibody produced in rabbit, IgG fraction of antiserum
HPA020626
Anti-CCNA2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106206
Anti-CCNA2 antibody produced in rabbit, affinity isolated antibody
SAB4600400
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF568 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
S8191
Anti-Survivin antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB3500269
Anti-Survivin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4501460
Anti-Survivin antibody produced in rabbit, affinity isolated antibody
WH0000332M1
Monoclonal Anti-BIRC5 antibody produced in mouse, clone 5B10, purified immunoglobulin, buffered aqueous solution
SAB4100131
Monoclonal Anti-BIRC5 antibody produced in mouse, clone BIRC5-A113, culture supernatant
SAB5300510 Monoclonal Anti-BIRC5 antibody produced in mouse, clone 2H5H2, ascites fluid
SAB5300511
Monoclonal Anti-BIRC5 antibody produced in mouse, clone 1H5, purified immunoglobulin, buffered aqueous solution